Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by inthnoon Mar 24, 2009 10:42am
275 Views
Post# 15865588

RE: RE: FDA or....

RE: RE: FDA or....Absolutely correct rjc....it was the application in the trial that was a concern....too bad that an unrelated trial had to affect us.
Where did all of the pumpers go.....and look at all of the increasing volume that they said and the news releases....I am sooo glad that they were here to help us so much with all of their informed information like yours rjc....
What they are now doing, is now they are on another board and pumping and taking advantage of the latest market run.
PS...rjc...I like your peanut analogy...very inciteful and please keep up the good work. Nice to have someone who actually knows what they are talking about around.
Bullboard Posts